{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Biologics and 30-Day Postoperative Complications After Abdominal Operations for Crohn?s Disease: Are There Differences in the Safety Profiles?

Description

The certificate for this activity is for PHYSICIANS.

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Review and outline the various postoperative outcomes after the preoperative use of biologics, immunomodulators, and non-biologics in the treatment of Crohn?s disease.
  2. Define and become familiar with the potential increased risk of infectious complications and intra-abdominal sepsis with combination therapy.
  3. Explain that increased risks associated with combined immunosuppression may be a surrogate marker of more severe disease rather than a result of biologic therapy.
Price: $10.00

Credits:

  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: DCR01119A
Published: November 2019
Expires: 10/10/2022
Passing Score: 4/4 (100%)
Authors: Amy L. Lightner, M.D., Nicholas P. McKenna, M.D., Ahmad Alsughayer, M.D., William S. Harmsen, M.S., Kekoa Taparra, Ph.D., Maile E. Parker, M.D., Laura E. Raffals, M.D., M.S., and Edward V. Loftus Jr., M.D.
Categories: Oncology , Surgical
Specialties: Surgical